MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,020 | +42.0% | 5,902 | +76.5% | 0.00% | – |
| Q2 2023 | $41,551 | -37.1% | 3,344 | -29.1% | 0.00% | – |
| Q1 2023 | $66,090 | +8.9% | 4,718 | +12.5% | 0.00% | – |
| Q4 2022 | $60,703 | -32.6% | 4,194 | +19.3% | 0.00% | – |
| Q3 2022 | $90,000 | +2.3% | 3,516 | +13.7% | 0.00% | – |
| Q2 2022 | $88,000 | -90.5% | 3,091 | -88.2% | 0.00% | -100.0% |
| Q1 2022 | $928,000 | +736.0% | 26,286 | +894.6% | 0.00% | – |
| Q4 2021 | $111,000 | -13.3% | 2,643 | +0.8% | 0.00% | – |
| Q3 2021 | $128,000 | -90.5% | 2,621 | -91.9% | 0.00% | -100.0% |
| Q2 2021 | $1,347,000 | +848.6% | 32,292 | +709.3% | 0.00% | – |
| Q1 2021 | $142,000 | +167.9% | 3,990 | +110.8% | 0.00% | – |
| Q4 2020 | $53,000 | – | 1,893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |